Milestone Pharmaceuticals Inc (MIST) Stock Price, Quote, News & History

MISTNASDAQ
$0.8892
-0.0385-4.15%
At close: Sep 15, 5:00 PM EST
$0.9300
0.00230.25%
Pre-Market: 7:56 AM EST

Milestone Pharmaceuticals (MIST) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-61.29M
Investing Cash Flow (TTM)
-319.00K
Financing Cash Flow (TTM)
188.84M
Free Cash Flow (TTM)
-61.65M
Capital Expenditure (TTM)
-356.00K
Net Change in Cash (TTM)
127.23M

Analyst Trends and Forecast

1
May
1
Aug
1
Sep
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$163.60K
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
44.77
PB Ratio (TTM)
6.08
Earnings Yield % (TTM)
-73.10%
Earnings Yield % (FWD)
-92.22%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.15

Company Debt

Total Debt
$59.21M
LT Debt
$59.21M
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$169.73M
Debt to Equity
3.30
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
$0.89
Volume / Avg.
16.77K / 1.51M
Day Range
- - -
52 Wk Range
0.88 - 3.06
Market Cap
$115.78M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
33
Short Interest
14.05%
Days to Cover
11.34

About

Sector
Health Care
Industry
Pharmaceuticals
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-admini...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Milestone Pharmaceuticals (MIST) stock?

A

You can purchase shares of Milestone Pharmaceuticals (NASDAQ:MIST) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Milestone Pharmaceuticals (MIST) competitors?

Q

What is the forecast, or price target, for Milestone Pharmaceuticals (MIST) stock?

A

Milestone Pharmaceuticals has a consensus price target of $7.38.

Q

What is the current price for Milestone Pharmaceuticals (MIST)?

A

The stock price for Milestone Pharmaceuticals (NASDAQ: MIST) is $0.93 last updated September 17, 2026 at 8:26 AM EDT.

Q

Does Milestone Pharmaceuticals (MIST) pay a dividend?

A

There are no upcoming dividends for Milestone Pharmaceuticals.

Q

When is Milestone Pharmaceuticals (NASDAQ:MIST) reporting earnings?

A

Milestone Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Milestone Pharmaceuticals (MIST) going to split?

A

There is no upcoming split for Milestone Pharmaceuticals.

Q

What sector and industry does Milestone Pharmaceuticals (MIST) operate in?

A

Milestone Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.